Drug
TB 500
TB 500: highest development phase Phase 1/2, developed by Hudson Biotech. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Hudson Biotech
Trials
| Drug | Phase | Indication |
|---|---|---|
| TB-500 NCT07487363 | Phase 1/2 | Atherosclerotic Cardiovascular Diseases |
Latest
No recent events.
Follow TB 500 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.